EAT is up +49.38%% since April’24 pick View All Top Buy Picks
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SKYE
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Skye Bioscience, Inc. stock price took a fall of -6.19% on Tuesday
(Updated on Jun 25, 2024)

Sell candidate since May 29, 2024 Loss -34.33% PDF

The Skye Bioscience, Inc. stock price fell by -6.19% on the last day (Tuesday, 25th Jun 2024) from $8.40 to $7.88. During the last trading day the stock fluctuated 7.45% from a day low at $7.79 to a day high of $8.37. The price has fallen in 6 of the last 10 days and is down by -21.04% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -44 thousand shares and in total, 279 thousand shares were bought and sold for approximately $2.20 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -23.23% during the next 3 months and, with a 90% probability hold a price between $4.04 and $10.84 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SKYE Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 21, 2024, and so far it has risen 1.42%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Skye Bioscience, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.12 and $11.20. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Skye Bioscience, Inc. stock

Skye Bioscience, Inc. finds support from accumulated volume at $7.77 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.580 between high and low, or 7.45%. For the last week, the stock has had daily average volatility of 22.29%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SKYE) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect Skye Bioscience, Inc. to open at $8.01, and during the day (based on 14 day Average True Range), to move between $6.68 and $9.08, which gives a possible trading interval of +/-$1.20 (+/-15.17%) up or down from last closing price. If Skye Bioscience, Inc. takes out the full calculated possible swing range there will be an estimated 30.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $7.77 (1.40%) than the resistance at $8.40 (6.60%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Skye Bioscience, Inc. stock A Buy?

Skye Bioscience, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.270 Strong Sell Candidate Unchanged

Predicted Opening Price for Skye Bioscience, Inc. of Wednesday, June 26, 2024

Fair opening price June 26, 2024 Current price
$8.01 ( 1.69%) $7.88

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SKYE

Fibonacci Support & Resistance Levels

Level Price
R3 8.59 9.05%
R2 8.37 6.24%
R1 8.23 4.50%
Price 7.88
S1 7.79 -1.12%
S2 7.65 -2.86%
S3 7.43 -5.67%

Accumulated Volume Support & Resistance Levels

Level Price
R3 9.51 20.69%
R2 8.93 13.32%
R1 8.40 6.60%
Price 7.88
S1 7.77 -1.40%
S2 0 -
S3 0 -

FAQ

What is the symbol for Skye Bioscience, Inc. Stock and on which exchange is it traded?
The symbol for Skye Bioscience, Inc. is SKYE and it is traded on the PINK (Pink Sheets).

Should I buy or sell Skye Bioscience, Inc. Stock?
Skye Bioscience, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Skye Bioscience, Inc. Stock?
Skye Bioscience, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Skye Bioscience, Inc. Stock.

What's the current price of Skye Bioscience, Inc. Stock?
As of the end of day on the Jun 25, 2024, the price of an Skye Bioscience, Inc. (SKYE) share was $7.88.

What is the 52-week high and low for Skye Bioscience, Inc. Stock?
The 52-week high for Skye Bioscience, Inc. Stock is $19.41 and the 52-week low is $0.0074.

What is the market capitalization of Skye Bioscience, Inc. Stock?
As of the Jun 25, 2024, the market capitalization of Skye Bioscience, Inc. is 235.77M.

When is the next earnings date for Skye Bioscience, Inc.?
The upcoming earnings date for Skye Bioscience, Inc. is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Skye Bioscience, Inc.

Skye Bioscience. Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degenerati... SKYE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT